MARYEM KIANINEJAD: Open Payments
NPI 1831638386 · THORNTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 38 payments from 13 companies in 2025. Trend: 2023 $1,440 · 2024 $1,322 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $131 |
| Novo Nordisk Inc | 5 | $116 |
| Lilly USA, LLC | 5 | $96 |
| Amgen Inc. | 4 | $72 |
| Amneal Pharmaceuticals LLC | 4 | $70 |
| Sumitomo Pharma America, Inc. | 1 | $56 |
| PFIZER INC. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
Products named: MOUNJARO, UNITHROID, Wegovy, BREZTRI, GEMTESA, OTEZLA, PREVNAR 20, JARDIANCE.
Industry payments across CO — which companies pay providers there.
